3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
3
Terminated
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
92
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Leukemia, Myeloid, Acute
79
Leukemia
41
Myeloproliferative Disorders
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30
Multiple Myeloma
21
Leukemia, Myeloid, Chronic-Phase
20
Lymphoma, Non-Hodgkin
18
Lymphoma
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Leukemia, Myelomonocytic, Chronic
16
Polycythemia Vera
14
Hodgkin Disease
14
Primary Myelofibrosis
11
Lymphoma, Large B-Cell, Diffuse
11
Neoplasms, Plasma Cell
10
Lymphoma, Follicular
10
Hematologic Neoplasms
10
Burkitt Lymphoma
10
Recurrence
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Anemia, Refractory, with Excess of Blasts
9
Myelodysplastic-Myeloproliferative Diseases
8
Mastocytosis, Systemic
8
Mastocytosis
8
Lymphoma, Mantle-Cell
8
Lymphoma, Large-Cell, Immunoblastic
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Accelerated Phase
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Primary Immunodeficiency Diseases
×
Myeloid
×
Clear all
NCT03836690
2019-10-25
ToTem
University College, London
Phase 1
Unknown
18 enrolled